Phase Ib Trial Of Avid200 In Refractory Myelofibrosis

2022 4:15

AVID200 is a selective TGFβ1/3 protein trap under investigation as a novel treatment option for patients with intermediate-2 or ...

Choose a download method below. All links open in new tabs.

Service	Features	Action
SaveFrom	MP4 & MP3 • HD Quality • Browser Extension Available	Download

Security Notice: These are third-party services. We recommend using antivirus software and being cautious of pop-up ads.